APA (7e ed.) Bronvermelding

Brunschwig, C., Lawrence, N., Taylor, D., Abay, E., Njoroge, M., Basarab, G., . . . Chibale, K. (2018). UCT943, a next generation plasmodium falciparum PI4K inhibitor preclinical candidate for the treatment of malaria. American Society for Microbiology.

Chicago (17e ed.) Bronvermelding

Brunschwig, C., et al. UCT943, a Next Generation Plasmodium Falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria. American Society for Microbiology, 2018.

MLA (9e ed.) Bronvermelding

Brunschwig, C., et al. UCT943, a Next Generation Plasmodium Falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria. American Society for Microbiology, 2018.